New Cancer Drug ETC-159 Enters Phase 1B of Clinical Trials
Cancer drug developed in Singapore by Duke-NUS Medical School and the Agency for Science, Technology and Research (A*STAR) with applications in cancer immunotherapy takes its first steps into the...